Tom Spencer

JANUARY 31, 2025

In recent years, there have been large M&A deals involving pharmaceutical and biotechnology companies, and a significant area of expansion in the technology space – health tech. The global life sciences consulting market is expected to grow by around 10% per year from 2024 to 2029. What is life sciences consulting?

Biotechnology 88

Biotechnology Healthcare Pharmaceuticals Consulting 88

Harvard Business

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. This information will ultimately support critical drug development decisions.

Data 70

Data Pharmaceuticals Biotechnology Methodologies 70

Harvard Business

JUNE 16, 2016

The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. One of the major advantages of this more integrated approach is that product developers can steer discovery-driven researchers in more fruitful directions. Killing Ideas Faster.

Government 70

Government Research Journal Biotechnology 70

Tom Spencer

JANUARY 17, 2025

As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. On the one hand, streamlining regulations and reducing bureaucratic hurdles could accelerate the development and approval of new therapies.

Policies 88

Policies Healthcare Biotechnology Industry 88